360
Participants
Start Date
November 30, 2023
Primary Completion Date
February 29, 2024
Study Completion Date
June 30, 2024
NanaBis™
NanaBis™ is a nanoparticle water soluble equimolar solution of d9-THC \& CBD. One dose is equivalent to 2 actuations of the pump delivering 280 µL volume containing 2.5 mg d9-THC and 2.5 mg CBD
Oxycodone CR
Oxycodone CR tablet is an opioid agonist supplied in 10 mg, 15 mg, 20 mg, 30 mg,40 mg, 60 mg and 80 mg tablets for oral administration. The tablet strengths describe the amount of oxycodone per tablet as the hydrochloride salt.
Placebo Spray
Placebo comparator used against both NanaBis™ and Oxycodone depending on randomisation of arms.
Placebo Tablet
Placebo comparator used against both NanaBis™ and Oxycodone depending on randomisation of arms.
Oxycodone IR
Oxycodone immediate release (IR) tablet or capsule or oral solution used as breakthrough analgesia.
Lead Sponsor
Collaborators (1)
Emerald Clinical Inc.
INDUSTRY
WriteSource Medical Pty Ltd
UNKNOWN
Medlab Clinical
INDUSTRY